Examining Health Equity Among Different Racial and Ethnic Subpopulations With Multiple Sclerosis - Episode 8

Implications of Treatment Affordability Issues

In a consensus paper updated in 2019, the MS Coalition stated that giving patients access to all FDA-approved DMTs was imperative for optimal management of MS. A broad range of therapy options are important for adults with early and active disease — the latter being more likely to be experienced by Black or Hispanic patients. In addition, because Black patients may experience lower efficacy with certain DMTs, therapy options should not be restricted for this population. (14)

Conclusions